HOW TO DELIVER AEROSOLIZED MEDICATIONS THROUGH HIGH FLOW NASAL CANNULA SAFELY AND EFFECTIVELY IN THE ERA OF COVID-19 AND BEYOND: A NARRATIVE REVIEW

How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review

Background The treatments of COVID-19 involve some degree of uncertainty.Current evidence also shows mixed findings with regards to bioaerosol dispersion and airborne transmission of COVID-19 during high flow nasal cannula (HFNC) therapy.While coping with this global pandemic created hot debates on the use of HFNC, it is important to bring detached

read more


Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)

CKD519, a selective inhibitor of cholesteryl ester transfer protein(CETP), is undergoing development as an oral agent for the treatment of primary hypercholesterolemia and mixed hyperlipidemia.The aim of this study was to predict the appropriate efficacious dose of CKD519 for humans in terms of the inhibition of CETP activity by developing a CKD519

read more